---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047420"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T20:16:00.957197+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Enveric Biosciences receives Nasdaq delisting notice on Nov 20 for bid price failure

## Summary
- Nasdaq notified Enveric on Nov 20, 2024, that it failed to meet the $1.00 minimum bid price requirement by the Nov 12 compliance deadline.
- Company not eligible for a second 180-day extension due to insufficient stockholders' equity (below $5M initial listing requirement).
- Enveric intends to appeal and request a hearing before the Nasdaq Listing Qualifications Panel.
- Appeal stays delisting and trading suspension pending Panel decision; no guarantee of favorable outcome.

## SEC filing metadata
- accession: 0001493152-24-047420
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315224047420/0001493152-24-047420-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315224047420/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047420
- JSON: https://secwatch.observer/filing/0001493152-24-047420.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047420.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.